| Date Filed | Type | Description |
| 08/17/2023 |
4
| NEUMANN CLARKE (See Remarks) has filed a Form 4 on BIORA THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 36,183 shares
@ $3.14, valued at
$113.6k
Granted 210,175 shares
@ $0 |
|
| 05/17/2023 |
4
| NEUMANN CLARKE (See Remarks) has filed a Form 4 on BIORA THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 2,368 shares
@ $3.35, valued at
$7.9k
|
|
| 03/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| NEUMANN CLARKE (See Remarks) has filed a Form 4 on BIORA THERAPEUTICS, INC.|
Txns:
| Disposed/sold 44 shares
@ $0 |
|
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2022 |
4
| NEUMANN CLARKE (See Remarks) has filed a Form 4 on BIORA THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,355 shares
@ $1.04, valued at
$1.4k
|
|
| 05/17/2022 |
4
| NEUMANN CLARKE (See Remarks) has filed a Form 4 on BIORA THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 8,305 shares
@ $0.75, valued at
$6.2k
Granted 239,962 shares
@ $0
Granted 387,752 options to buy
@ $0.75, valued at
$290.8k
|
|
| 04/19/2022 |
4
| NEUMANN CLARKE (See Remarks) has filed a Form 4 on PROGENITY, INC.|
Txns:
| Granted 184,843 shares
@ $0
Granted 299,197 options to buy
@ $1, valued at
$299.2k
|
|
| 02/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2021 |
4
| NEUMANN CLARKE (See Remarks) has filed a Form 4 on PROGENITY, INC.|
Txns:
| Paid exercise price by delivering 752 shares
@ $3.47, valued at
$2.6k
|
|
| 08/17/2021 |
4
| NEUMANN CLARKE (See Remarks) has filed a Form 4 on PROGENITY, INC.|
Txns:
| Paid exercise price by delivering 2,336 shares
@ $1.66, valued at
$3.9k
|
|
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| NEUMANN CLARKE (General Counsel and Secretary) has filed a Form 4 on PROGENITY, INC.|
Txns:
| Paid exercise price by delivering 1,726 shares
@ $6.32, valued at
$10.9k
|
|
| 08/18/2020 |
4
| NEUMANN CLARKE (General Counsel and Secretary) has filed a Form 4 on PROGENITY, INC.|
Txns:
| Granted 20,534 shares
@ $0
Granted 42,114 options to buy
@ $7.71, valued at
$324.7k
Granted 19,423 options to buy
@ $9.88, valued at
$191.9k
Granted 6,474 options to buy
@ $9.88, valued at
$64k
Granted 19,422 options to buy
@ $9.88, valued at
$191.9k
Granted 34,800 options to buy
@ $9.76, valued at
$339.6k
|
|
| 06/18/2020 |
3
| NEUMANN CLARKE (General Counsel and Secretary) has filed a Form 3 on PROGENITY, INC. |
| 02/08/2012 |
4
| NEUMANN CLARKE (VP & General Counsel) has filed a Form 4 on SEQUENOM INC|
Txns:
| Granted 933 shares
@ $0
Paid exercise price by delivering 390 shares
@ $4.92, valued at
$1.9k
Granted 235 shares
@ $0
Paid exercise price by delivering 98 shares
@ $4.92, valued at
$482.2
Granted 17,640 options to buy
@ $4.92, valued at
$86.8k
Granted 25,360 options to buy
@ $4.92, valued at
$124.8k
|
|
| 07/19/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/10/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/02/2011 |
4
| NEUMANN CLARKE (VP & General Counsel) has filed a Form 4 on SEQUENOM INC|
Txns:
| Sold 500 shares
@ $7.072, valued at
$3.5k
|
|
| 04/08/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2011 |
4
| NEUMANN CLARKE (VP & General Counsel) has filed a Form 4 on SEQUENOM INC|
Txns:
| Sold 1,000 shares
@ $6.123, valued at
$6.1k
|
|
| 02/14/2011 |
4
| NEUMANN CLARKE (VP & General Counsel) has filed a Form 4 on SEQUENOM INC|
Txns:
| Granted 13,997 options to buy
@ $6.7, valued at
$93.8k
|
|
| 01/04/2011 |
4
| NEUMANN CLARKE (VP & General Counsel) has filed a Form 4 on SEQUENOM INC|
Txns:
| Sold 1,000 shares
@ $8.06, valued at
$8.1k
|
|
| 08/04/2010 |
4
| NEUMANN CLARKE (VP & General Counsel) has filed a Form 4 on SEQUENOM INC|
Txns:
| Granted 10,417 options to buy
@ $5.92, valued at
$61.7k
Granted 14,583 options to buy
@ $5.92, valued at
$86.3k
|
|
| 02/24/2009 |
4/A
| Form 4/A -- Statement of changes in beneficial ownership of securities [amend] |
| 02/24/2009 |
3/A
| Neumann Clarke (VP & General Counsel) has filed a Form 3/A on SEQUENOM INC |
| 02/11/2009 |
4
| Neumann Clarke (VP & General Counsel) has filed a Form 4 on SEQUENOM INC |
| 01/20/2009 |
4
| Neumann Clarke (VP & General Counsel) has filed a Form 4 on SEQUENOM INC |